Story perspectives

Revolutionary Genome Test Enhances Rare Disease Diagnosis

11/18/2025

Summary

Story summary

Radboud University Medical Center (Radboudumc) and Maastricht University Medical Center+ (Maastricht UMC+) launched a long-read genome sequencing test to diagnose rare diseases, marking the first large-scale clinical use.
The test replaces around 15 other tests and offers broader DNA mapping.
Experts say the innovation will improve diagnostic accuracy and treatment.
Initially, 5,000 tests will focus on genetic forms of blindness and severe intellectual disabilities.

1 of 1

Story summary

Radboud University Medical Center (Radboudumc) and Maastricht University Medical Center+ (Maastricht UMC+) launched a long-read genome sequencing test to diagnose rare diseases, marking the first large-scale clinical use.
The test replaces around 15 other tests and offers broader DNA mapping.
Experts say the innovation will improve diagnostic accuracy and treatment.
Initially, 5,000 tests will focus on genetic forms of blindness and severe intellectual disabilities.